Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control Study David T. Rubin, Dezheng Huo, Jami A. Kinnucan, Mina S. Sedrak, Nicole E. McCullom, Alana P. Bunnag, Elin P. Raun–Royer, Russell D. Cohen, Stephen B. Hanauer, John Hart, Jerrold R. Turner Clinical Gastroenterology and Hepatology Volume 11, Issue 12, Pages 1601-1608.e4 (December 2013) DOI: 10.1016/j.cgh.2013.06.023 Copyright © 2013 AGA Institute Terms and Conditions
Figure 1 ORs and 95% CIs of CRC and dysplasia by inflammation score calculated in the univariate and multivariate conditional logistic regressions. The multivariate ORs were adjusted by immune modulator, nonsulfasalazine mesalamine use, and sex. Clinical Gastroenterology and Hepatology 2013 11, 1601-1608.e4DOI: (10.1016/j.cgh.2013.06.023) Copyright © 2013 AGA Institute Terms and Conditions
Supplementary Figure 1 University of Chicago scale of histologic inflammation in colitis. Clinical Gastroenterology and Hepatology 2013 11, 1601-1608.e4DOI: (10.1016/j.cgh.2013.06.023) Copyright © 2013 AGA Institute Terms and Conditions